Draft Policies for Public Comment
This policy sets forth changes to ACS expectations regarding obtaining and documenting informed consent from parent(s)/guardian(s) when psychiatric medications have been prescribed. The policy outlines the process by which ACS and agencies must make reasonable efforts to obtain informed consent, how such efforts must be documented, and how authorization from ACS’ Psychiatry and Behavioral Health Unit (PBHU) may be requested when parental consent cannot be obtained and for requesting an override of a parent’s affirmative objection. In addition, PBHU will concurrently review prescriptions for certain medications for clinical appropriateness
This policy is being submitted for a 30-day review period. We value your feedback and welcome your comments via email to email@example.com no later than June 29, 2018. Comments can also be sent by mail to: ACS Policy Unit, 150 William St., 17th Floor, NY, NY 10038. Following a review of the submitted comments, this policy will be issued as final and the case practice expectations and requirements articulated within will become effective. Read more
Please do not hesitate to contact me with any questions or concerns.